BioSpace News Archive

Theravance Biopharma, Inc. will participate in a Fireside Chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15 at 8:00 am ET.

Madorra announces publication of positive Pilot 1 randomized controlled trial results for the company’s non-invasive, home-use device for women experiencing moderate to severe vulvovaginal atrophy, a component of genitourinary syndrome of menopause.

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 23, 2023. Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 23, 2023.

Karuna Therapeutics, Inc. today announced that management will present at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 2:20 p.m. EST.

Adiso Therapeutics, Inc. has appointed Srikar Guntaka , M.D., as its Medical Director.

LAVA Therapeutics N.V. today announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will present at the 2023 SVB Securities Global Biopharma Conference.

Entrada Therapeutics, Inc. today announced the expiration of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 and closing of the Company’s previously announced strategic collaboration and license agreement with Vertex.

Compugen Ltd. today announced that management will present at the SVB Securities Global Biopharma Conference (virtual), on Thursday, February 16, 2023 at 9:20 AM ET.